课题基金 / 基金详情

Developing a clinical decision support tool for the identification, diagnosis, and treatment of critical illness in hospitalized patients

Developing a clinical decision support tool for the identification, diagnosis, and treatment of critical illness in hospitalized patients
开发用于住院患者危重疾病识别、诊断和治疗的临床决策支持工具
批准号:
10683402
负责人:
Matthew Michael Churpek
金额:
$56.72万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-01 至 2025-07-31

项目摘要

项目成果

Matthew Michael Churpek的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Up to 5% of hospitalized adult patients on the medical-surgical wards develop clinical deterioration requiring intensive care. Medical errors are common before deterioration events, including delays and misjudgments in identification, diagnosis, and treatment, and these errors lead to increased morbidity and mortality. Therefore, it is critically important to improve the care of high-risk ward patients to decrease preventable in-hospital deaths. The current paradigm for attempting to decrease mortality from deterioration has several limitations. First, most early warning scores designed to identify high-risk patients are based only on vital signs and have limited accuracy. Clinical notes are an underutilized, rich source of information comprising nearly 80% of electronic health record (EHR) data. Natural language processing (NLP) can extract important risk factors from clinical notes for machine learning models to improve accuracy over existing tools. Second, current early warning scores only tell clinicians that a patient is at high risk but provide no information regarding what clinical condition is causing a patient’s deterioration. This leads to diagnostic and treatment errors, which results in worse patient outcomes. Developing tools to enhance diagnostic accuracy for high-risk ward patients could lead to fewer medical errors, decreased costs, and improved outcomes. Third, the initial treatment decisions for deteriorating patients are made by clinicians with limited experience caring for critically ill patients, which can result in delays of potentially life-saving therapies. By utilizing a large, granular, multicenter dataset, algorithms to predict the treatments a patient should receive can be developed, resulting in early, targeted, potentially life-saving therapy. The long-term goal is to develop and implement clinically useful decision support tools to decrease preventable death from deterioration. The overall objective of this project is to develop a clinical decision support tool for the identification, diagnosis, and treatment of patients at high risk of deterioration. This objective will be pursued in the following three specific aims: 1) Develop machine learning models to identify patients at high risk of deterioration using both structured data and unstructured clinical notes; 2) Develop models to predict the diagnosis that is causing the deterioration event and the potentially life-saving treatments that should be provided to high-risk patients; 3) Develop a clinical decision support tool with a graphical user interface incorporating the models from Aims 1 and 2 via user-centered design principles and then test its effectiveness, efficiency, and user satisfaction in a case-based simulation study. This research is innovative because it will utilize NLP, reinforcement learning, interpretable machine learning, and multi-task transfer learning approaches. The proposed research is significant because it will provide clinicians with powerful new tools that can be implemented in the EHR to identify, diagnose, and make treatment recommendations for high-risk patients. This will result in the delivery of early, personalized care to decrease preventable death from deterioration.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.48550/arxiv.2204.03035
发表时间: 2022-04
期刊: LREC ... International Conference on Language Resources & Evaluation : [proceedings]. International Conference on Language Resources & Evaluation
影响因子: --
作者: [Yanjun Gao;Dmitriy Dligach;Timothy Miller;S. Tesch;Ryan Laffin;M. Churpek;M. Afshar]
通讯作者: Yanjun Gao;Dmitriy Dligach;Timothy Miller;S. Tesch;Ryan Laffin;M. Churpek;M. Afshar
Sepsis Early Prediction and Subphenotype Illumination Study (SEPSIS)
  • 批准号:
    10405298
  • 项目类别:
  • 资助金额:
    $38.88万
  • 财政年份:
    2022
  • 负责人:
    Matthew Michael Churpek
  • 依托单位:
Sepsis Early Prediction and Subphenotype Illumination Study (SEPSIS)
  • 批准号:
    10615855
  • 项目类别:
  • 资助金额:
    $38.88万
  • 财政年份:
    2022
  • 负责人:
    Matthew Michael Churpek
  • 依托单位:
Developing a clinical decision support tool for the identification, diagnosis, and treatment of critical illness in hospitalized patients
  • 批准号:
    10454182
  • 项目类别:
  • 资助金额:
    $55.5万
  • 财政年份:
    2021
  • 负责人:
    Matthew Michael Churpek
  • 依托单位:
Developing a clinical decision support tool for the identification, diagnosis, and treatment of critical illness in hospitalized patients
  • 批准号:
    10182492
  • 项目类别:
  • 资助金额:
    $57.44万
  • 财政年份:
    2021
  • 负责人:
    Matthew Michael Churpek
  • 依托单位: